NV
Novo Integrated Sciences, Inc.
NVOS · OTC
$0.00 +0.00% (+$0.00)
1M +550.00%
Market Cap $76.9K
P/E Ratio -
Div. Yield -
ROE 91.57%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
P/B 0.01x
P/E N/A
Growth
61 /100
Stable Rev. growth 12.63%
Book val. growth 30.24%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 43.20%
Net margin 121.61%
Op. margin 62.54%
Quality
5 /100
Poor ROIC 40.13%
ROE 91.57%
ROA 50.30%
Debt
46 /100
Moderate Debt/Equity 0.32x
Current ratio 0.37x
Int. coverage -1.23x
Stability
26 /100
Unstable Beta 5.83x
Rev. volatility 11.40%
EPS volatility 339.72%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NVOS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert Mattacchione
Employees
115
Headquarters
Bellevue